LeonaBio director granted 56,000 stock options
LeonaBio, Inc. director Callori Fred received a grant of stock options covering 56,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
LeonaBio, Inc. director Callori Fred received a grant of stock options covering 56,000 shares of common stock. The options have an exercise price of $9.63 per share and expire on May 4, 2036. All 56,000 options are held directly after this award.
The options are scheduled to vest in equal installments monthly over 36 months from the grant date, as long as the director continues to serve as a service provider under LeonaBio’s 2026 Equity Incentive Plan.
Insider Trade Summary
Grant/Award: 56,000 shares
Grant/Award
1 txn
Insider
Callori Fred
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 56,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 56,000 options (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 56,000 options (Direct)
Footnotes (1)
- F1. The shares subject to the option are scheduled to vest monthly over a term of 36 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates.
Key Figures
Option grant size: 56,000 options
Exercise price: $9.63 per share
Expiration date: May 4, 2036
+3 more
6 metrics
Option grant size
56,000 options
Stock Option (Right to Buy) awarded to director
Exercise price
$9.63 per share
Conversion or exercise price for the options
Expiration date
May 4, 2036
Option term end date
Underlying shares
56,000 shares
Common stock underlying the options
Vesting period
36 months
Monthly vesting schedule from grant date
Post-transaction derivative holdings
56,000 options
Total options held directly after grant
Key Terms
Stock Option (Right to Buy), vest, Equity Incentive Plan, derivative
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
vest financial
"shares subject to the option are scheduled to vest monthly over a term of 36 months"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Equity Incentive Plan financial
"as defined in the Issuer's 2026 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
derivative financial
"transaction_type: derivative"
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LeonaBio (LONA) director Callori Fred report in this Form 4?
Callori Fred reported receiving a grant of stock options for 56,000 shares of LeonaBio common stock. These options were awarded at an exercise price of $9.63 per share and represent compensation rather than an open-market stock purchase or sale.
How many LeonaBio (LONA) options did Callori Fred receive and at what price?
Callori Fred received stock options covering 56,000 shares of LeonaBio common stock. The options carry an exercise price of $9.63 per share, meaning this is the price at which the director can buy shares if the options are exercised.
When do Callori Fred’s LeonaBio (LONA) stock options vest?
The 56,000 LeonaBio stock options are scheduled to vest monthly over 36 months following the grant. Vesting occurs on each monthly anniversary of the grant date, provided Callori Fred continues as a service provider under the company’s 2026 Equity Incentive Plan.
When do the LeonaBio (LONA) options granted to Callori Fred expire?
The stock options granted to Callori Fred are scheduled to expire on May 4, 2036. After this expiration date, any unexercised options will lapse and can no longer be used to purchase LeonaBio common shares at the stated exercise price.
How many LeonaBio (LONA) options does Callori Fred hold after this grant?
Following this reported transaction, Callori Fred holds 56,000 stock options directly. These options each relate to one share of LeonaBio common stock and are subject to the vesting and expiration terms described in the company’s equity incentive plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
